Patents by Inventor Stewart BLOOMFIELD

Stewart BLOOMFIELD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of using gap junctions as therapeutic targets for the treatment of degenerative disorders of the retina
    Patent number: 12178846
    Abstract: The disclosure provides methods of treating a condition of the retina by administering an inhibitor of connexin 36 and/or an inhibitor of connexin 45 to a subject with a retinal condition. This disclosure further provides compositions for the treatment of a retinal condition which include an inhibitor of connexin 36 and/or an inhibitor of connexin 45.
    Type: Grant
    Filed: August 28, 2017
    Date of Patent: December 31, 2024
    Assignee: The Research Foundation for The State University of New York
    Inventor: Stewart Bloomfield
  • METHODS OF USING GAP JUNCTIONS AS THERAPEUTIC TARGETS FOR THE TREATMENT OF DEGENERATIVE DISORDERS OF THE RETINA
    Publication number: 20170354710
    Abstract: The disclosure provides methods of treating a condition of the retina by administering an inhibitor of connexin 36 and/or an inhibitor of connexin 45 to a subject with a retinal condition. This disclosure further provides compositions for the treatment of a retinal condition which include an inhibitor of connexin 36 and/or an inhibitor of connexin 45.
    Type: Application
    Filed: August 28, 2017
    Publication date: December 14, 2017
    Applicant: The Research Foundation for The State University of New York
    Inventor: Stewart Bloomfield
  • METHODS OF USING GAP JUNCTIONS AS THERAPEUTIC TARGETS FOR THE TREATMENT OF DEGENERATIVE DISORDERS OF THE RETINA
    Publication number: 20170106047
    Abstract: The disclosure provides methods of treating a condition of the retina by administering an inhibitor of connexin 36 and/or an inhibitor of connexin 45 to a subject with a retinal condition. This disclosure further provides compositions for the treatment of a retinal condition which include an inhibitor of connexin 36 and/or an inhibitor of connexin 45.
    Type: Application
    Filed: June 11, 2015
    Publication date: April 20, 2017
    Applicant: THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
    Inventor: Stewart BLOOMFIELD